Lyra Therapeutics, Inc. (LYRA) Ownership
LYRA ownership summary
as of October 21, 2026- Institutions
- 6.6% of shares outstanding
- Insiders
- 0.62% of shares outstanding
- Shares outstanding
- 1.8M
- Float
- 440K shares available to trade
- Short interest
- 2.82% 17K shares short
- Days to cover
- 0.65 short interest down 70.7% vs prior month
- Institutions 6.64%
- Insiders 0.62%
- Other investors 92.74%
LYRA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Sabby Management LLC | 5.86% | 104K | $19,771 | −71,099 (−40.6%) | March 31, 2026 |
| 2 | EverSource Wealth Advisors, LLC | 0.00% | — | — | −338 (−100.0%) | March 31, 2026 |
| 3 | Bryn Mawr Trust Company | 0.00% | — | — | −20 (−100.0%) | March 31, 2026 |
| 4 | DRW Securities, LLC | 0.00% | — | — | −16,812 (−100.0%) | March 31, 2026 |
| 5 | Ikarian Capital, LLC | 0.00% | — | — | −21,161 (−100.0%) | March 31, 2026 |
| 6 | BlackRock Inc | 0.00% | — | — | −2,394 (−100.0%) | March 31, 2026 |
| 7 | Royal Bank of Canada | 0.00% | — | — | −1,953 (−100.0%) | March 31, 2026 |
| 8 | Tower Research Capital LLC | 0.00% | — | — | −2,191 (−100.0%) | March 31, 2026 |
| 9 | Citigroup Inc | 0.00% | — | — | −3 (−100.0%) | March 31, 2026 |
| 10 | Global Retirement Partners, LLC. | 0.00% | — | — | −15 (−100.0%) | June 30, 2026 |
| 11 | UBS Group AG | 0.00% | — | — | −675 (−100.0%) | March 31, 2026 |
| 12 | BNP Paribas Arbitrage, SA | 0.00% | — | — | −16 (−100.0%) | March 31, 2026 |
| 13 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −334 (−100.0%) | March 31, 2026 |
| 14 | Artia Global Partners LP | 0.00% | — | — | −8,756 (−100.0%) | March 31, 2026 |
| 15 | Geode Capital Management, LLC | 0.00% | — | — | −12,249 (−100.0%) | March 31, 2026 |
| 16 | JONES FINANCIAL COMPANIES LLLP | 0.00% | — | — | −210 (−100.0%) | March 31, 2026 |
| 17 | JPMorgan Chase & Co | 0.00% | — | — | −27 (−100.0%) | March 31, 2026 |
| 18 | SBI Securities Co Ltd | 0.00% | — | — | −80 (−100.0%) | March 31, 2026 |
| 19 | Advisor Group Holdings, Inc. | 0.00% | — | — | −22 (−100.0%) | March 31, 2026 |
| 20 | IFP Advisors, LLC | 0.00% | — | — | −1 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 0 holders added 0 shares and 20 cut 138K.
LYRA top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Extended Equity Market Fund B | 0.09% | 1,633 | $310 | — | December 31, 2025 |
| 2 | Extended Equity Market Fund E | 0.09% | 1,633 | $310 | — | December 31, 2025 |
Funds report holdings monthly or quarterly; dates differ by fund.
LYRA insider transactions
latest 10| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | Jason Cavalier | Sell | $3.36 | 769 | $2,584 |
| 2026-01-06 | Maria Palasis | Sell | $3.36 | 1,702 | $5,719 |
| 2025-11-13 | Perceptive Advisors Llc | Sell | $3.90 | 31,810 | $124,059 |
| 2025-11-12 | Perceptive Advisors Llc | Sell | $4.06 | 8,745 | $35,505 |
| 2025-11-11 | Perceptive Advisors Llc | Sell | $4.31 | 5,320 | $22,929 |
| 2025-11-10 | Perceptive Advisors Llc | Sell | $4.54 | 18,502 | $83,999 |
| 2025-11-07 | Perceptive Advisors Llc | Sell | $4.75 | 19,739 | $93,760 |
| 2025-11-06 | Perceptive Advisors Llc | Sell | $5.18 | 32,149 | $166,532 |
| 2025-07-10 | Jason Cavalier | Sell | $8.91 | 684 | $6,094 |
| 2025-07-10 | Maria Palasis | Sell | $8.91 | 1,565 | $13,944 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LYRA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LYRA
Institutional investors own 6.6% of Lyra Therapeutics's shares and insiders 0.62%. The largest holder is Sabby Management LLC with 5.86% of the shares (104K), as of March 31, 2026. Among the top 20 institutions, 0 added shares and 20 reduced their stake in the latest filings. Short interest is 2.82% of the float, or 0.65 days of average trading volume. The share count rose 89.8% since 2019.
Related: LYRA analyst forecast, LYRA key metrics. See the LYRA stock overview for the latest quote and news.
LYRA ownership FAQ
Who owns the most Lyra Therapeutics stock?
The largest shareholders of Lyra Therapeutics are Sabby Management LLC (5.86%), EverSource Wealth Advisors, LLC (0.00%), Bryn Mawr Trust Company (0.00%), DRW Securities, LLC (0.00%), Ikarian Capital, LLC (0.00%).
What percentage of Lyra Therapeutics is owned by institutions?
Institutions hold 6.6% of Lyra Therapeutics's shares outstanding; insiders hold 0.62%.
Which funds own Lyra Therapeutics?
The largest fund holders of Lyra Therapeutics are Extended Equity Market Fund B (0.09%), Extended Equity Market Fund E (0.09%).
What is Lyra Therapeutics's short interest?
17K shares of Lyra Therapeutics were sold short, 2.82% of the float; at the average daily volume it would take 0.65 days to cover.
Are insiders buying or selling Lyra Therapeutics?
Of the latest 10 reported insider transactions in Lyra Therapeutics (since July 10, 2025), 0 were purchases and 10 were sales.
How many shares of Lyra Therapeutics are outstanding?
Lyra Therapeutics has 1.8M shares outstanding, of which 440K are in the public float.